Reverse Triggering: An Introduction to Diagnosis, Management, and Pharmacologic Implications

1Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Reverse triggering is an underdiagnosed form of patient-ventilator asynchrony in which a passive ventilator-delivered breath triggers a neural response resulting in involuntary patient effort and diaphragmatic contraction. Reverse triggering may significantly impact patient outcomes, and the unique physiology underscores critical potential implications for drug-device-patient interactions. The purpose of this review is to summarize what is known of reverse triggering and its pharmacotherapeutic consequences, with a particular focus on describing reported cases, physiology, historical context, epidemiology, and management. The PubMed database was searched for publications that reported patients presenting with reverse triggering. The current body of evidence suggests that deep sedation may predispose patients to episodes of reverse triggering; as such, providers may consider decreasing sedation or modifying ventilator settings in patients exhibiting ventilator asynchrony as an initial measure. Increased clinician awareness and research focus are necessary to understand appropriate management of reverse triggering and its association with patient outcomes.

Cite

CITATION STYLE

APA

Murray, B., Sikora, A., Mock, J. R., Devlin, T., Keats, K., Powell, R., & Bice, T. (2022, June 22). Reverse Triggering: An Introduction to Diagnosis, Management, and Pharmacologic Implications. Frontiers in Pharmacology. Frontiers Media S.A. https://doi.org/10.3389/fphar.2022.879011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free